Navigation Links
Medical experts: US unlikely to have enough vaccines to stop avian flu

A group of medical experts who attended a national avian flu conference last fall believe there is little chance the United States will be able to manufacture and stockpile enough vaccine or antiviral medication to stop a bird flu pandemic should the virus mutate into a form that can be spread easily from human to human, according to a survey led by researchers at Carnegie Mellon University. The results of the survey will be published in the June 2006 issue of the journal Global Public Health.

The 19 medical experts who attended the Pandefense 1.0 meeting in November gave a median estimate of a less than 1 percent chance that the U.S. will have adequate stockpiles of vaccines or antiviral drugs to prevent a pandemic within the next three years. The same experts gave a median estimate of 15 percent for the probability that the avian flu virus will mutate into a strain that can spread efficiently by human-to-human contact within that time. Their median worst-case estimate of the number of people who would die, should that happen, was 6 million in the United States and 180 million worldwide. Their median best-case estimates were 500,000 dead in the United States and 20 million worldwide.

"It surprised me that they thought it was going to be this bad," said Wändi Bruine De Bruin, lead author of the study and research faculty member in the Department of Social and Decision Sciences at Carnegie Mellon.

The survey also included 17 non-medical experts from a variety of fields who were more pessimistic about the likelihood of human-to-human transmission, giving a median 60 percent chance that it would occur within three years. They did, however, have more faith in medical science, giving a median 15 percent chance of the United States having enough vaccine and a 30 percent chance that the nation would have enough antiviral medications to halt a pandemic.

"The medical experts' estimates suggest this is a bigger risk than anything else we are fa
'"/>

Source:Carnegie Mellon University


Page: 1 2

Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Medical whistleblowers speak out
4. Access to antiretrovirals unlikely to reduce HIV infection rates
5. Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study
6. Gene therapy to lower blood pressure just enough
7. A little telomerase isnt enough
8. Heart has enough oxygen to survive hypothermia, CPR crucial
9. Walking not enough for significant exercise benefits
10. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
11. Increase in drug development for killer diseases is not enough

Post Your Comments:
(Date:11/20/2009)...er 19, 2009 The estimated 4.6 million Americans i...eveloping respiratory symptoms due to poor air qua...study undertaken earlier this year by investigator...ary Medicine. , The studywhich polled more than ...cent of individuals working in barns complained of...
(Date:11/20/2009)...n German . , In the current online issue of...anie Eyerich and Dr. Kilian Eyerich together with ...Istituto Dermopatico dell,Immacolata in Rome, pres...a milestone on the way to developing new treatment...oriasis and allergic reactions and potentially als...
(Date:11/20/2009)...udy, researchers report that a class of heart medi...r harmful, effect on the heart, depending on their...in the journal Circulation Research , found that ...-receptors on the heart muscle offer the most bene...nly the beta-receptors can actually undermine the ...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2Promising medical trainees receive funding to pursue research in hematology 51518 1Promising medical trainees receive funding to pursue research in hematology 51518 2American Society of Hematology awards grants to encourage novel medical training programs 51514 1American Society of Hematology awards grants to encourage novel medical training programs 51514 2Bausch 26 Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps 51511 1Bausch 26 Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps 51511 2Bausch 26 Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps 51511 3
...tists has discovered three molecules –?from a sear...key perpetrator of Alzheimer,s disease. , Each of ...au," which becomes hopelessly tangled in the brain...mising news for the development of drugs for the d...nce Research Institute at the University of Califo...
... tsunami that killed over a quarter of a million p...004, slowly disappear from the media, but the even... of those who are directly involved. In the afterm...ke are trying to investigate how the number of cas...t, how such severe damage can be avoided if a tsun...
...tists has discovered three molecules –?from a sear...key perpetrator of Alzheimer,s disease. , Each of ...au," which becomes hopelessly tangled in the brain...mising news for the development of drugs for the d...nce Research Institute at the University of Califo...
Other Biology News:Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels 2Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels 3Could better mangrove habitats have spared lives in the 2004 tsunami? 2Scientists discover that three molecules may be developed into new Alzheimer's drugs 2Scientists discover that three molecules may be developed into new Alzheimer's drugs 3
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Danis...nbicon cellulosic ethanol plant in Kalundborg, Den...ne of the world,s first and largest 2nd generation...ccellerase enzymes are used in the plant,s innovat..., a Division of Danisco, was the first to market w...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 /PRNewswire-FirstCall/...day that it has sent the following letter to its s... on October 30, 2009, of China Biopharmaceuticals ...tical company based in the People,s Republic of Ch...terest in Suzhou Eyre Pharmaceutical Co. Ltd., CHB...
(Date:11/19/2009)..., , MONTREAL, Nov. 19 /PRNewswire/ - Aegera ...e first patient in a randomized Phase 2B study of ...stage development for multiple oncology indication...ized Phase 2 Study of the X-Linked Inhibitor of Ap...tion with High-dose Cytarabine and Idarubicin in A...
(Date:11/19/2009)..., , VIENNA, Austria, November 19 /PR... vaccine program on one product candidate at an un... candidate AD02 is planned to enter into,Phase II ... company,immediately follows the completion of two... The company based its fast decision on the first ...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...ideo system , Optimized Imaging of Protein Gels... Michelle Cayouette Jane Moores ,Stratagene Clo...es an optical bandpass filter with all Eagle,Eye...sualizing,ethidium bromide fluorescence. However...dium bromide may be inadequate for use with other ...
... for robust, high-fidelity PCR,amplification ,...rie,Hedden Connie Hansen Janice Cline Frances ...ratagene , Stratagene announces the release of p...of Pfu DNA polymerase for high-fidelity,PCR. Pf...,polymerase and a novel thermostable factor that...
...chemiluminescent enhancer for increased sensitivit... (O 2 , ) , Danny Q. Hoang ,Stratagene ,...edicine, Dept. of Microbiology, Hanover, NH , St...y, a simple and unique chemiluminescent-based meth...oxide anions in cell culture. In addition, the kit...
Other Biology Technology:Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 2Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 3Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 4Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 2Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 3Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 4Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 5Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 6Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 7Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 8Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 9Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 10Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 11Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" ,) 2Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" ,) 3Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" ,) 4Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" ,) 5
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Goat Anti-SPFH2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Als2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: